Skip to main content
. 2017 Apr 7;11:32. doi: 10.1186/s13065-017-0258-4

Table 3.

The antitumor activities of the tested compounds expressed as IC50 values and compared with reference standard drugs evaluated on breast and liver cancer cell lines

Tested compounds IC50 values (µg/mL) against tumor cell lines
MCF-7 HepG2
3a >200 153.1 ± 2.3
3b NA NA
3c 41.9 ± 1.7 18.8 ± 1.1
3d >200 150.9 ± 3.7
3e >200 >200
4a 22.3 ± 1.5 4.8 ± 0.6
4b 46.1 ± 1.6 24.5 ± 1.2
4c 63.8 ± 1.2 45.2 ± 1.4
4d >200 >200
5-flourouracil 5.2 ± 0.5 4.9 ± 0.3
Cisplatin 19.1 ± 0.7 18.8 ± 0.6